|
|
 |
|
|
NOVARTIS AG
|
|
|
|
|
|
|
|
|
Novartis AG (NYSE: NVS) is a world leader in offering medicines to protect health, cure disease and improve well-being. Their goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. They are strengthening their medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group’s businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 101,000 associates and operate in over 140 countries around the world.
|
|
|
|
|
|
|
|
|
|
|
